[HTML][HTML] Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome

IM Rood, JKJ Deegens, ML Merchant, WPM Tamboer… - Kidney international, 2010 - Elsevier
IM Rood, JKJ Deegens, ML Merchant, WPM Tamboer, DW Wilkey, JFM Wetzels, JB Klein
Kidney international, 2010Elsevier
Urinary microvesicles, such as 40–100 nm exosomes and 100–1000 nm microparticles,
contain many proteins that may serve as biomarkers of renal disease. Microvesicles have
been isolated by ultracentrifugation or nanomembrane ultrafiltration from normal urine;
however, little is known about the efficiency of these methods in isolating microvesicles from
patients with nephrotic-range proteinuria. Here we compared three techniques to isolate
microvesicles from nephrotic urine: nanomembrane ultrafiltration, ultracentrifugation, and …
Urinary microvesicles, such as 40–100 nm exosomes and 100–1000 nm microparticles, contain many proteins that may serve as biomarkers of renal disease. Microvesicles have been isolated by ultracentrifugation or nanomembrane ultrafiltration from normal urine; however, little is known about the efficiency of these methods in isolating microvesicles from patients with nephrotic-range proteinuria. Here we compared three techniques to isolate microvesicles from nephrotic urine: nanomembrane ultrafiltration, ultracentrifugation, and ultracentrifugation followed by size-exclusion chromatography (UC-SEC). Highly abundant urinary proteins were still present in sufficient quantity after ultrafiltration or ultracentrifugation to blunt detection of less abundant microvesicular proteins by MALDI-TOF-TOF mass spectrometry. The microvesicular markers neprilysin, aquaporin-2, and podocalyxin were highly enriched following UC-SEC compared with preparations by ultrafiltration or ultracentrifugation alone. Electron microscopy of the UC-SEC fractions found microvesicles of varying size, compatible with the presence of both exosomes and microparticles. Thus, UC-SEC following ultracentrifugation to further enrich and purify microparticles facilitates the search for prognostic biomarkers that might be used to predict the clinical course of nephrotic syndrome.
Elsevier